Mutual Advisors, LLC Eli Lilly & CO Transaction History

Mutual Advisors, LLC

$3.73 Billion
Q2 2025

A detailed history of Mutual Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mutual Advisors, LLC holds 63,791 shares of LLY stock, worth $51 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares

63,791

Previous 63,463 0.52%

Holding current value

$51 Million

Previous $52.4 Million 5.13%

% of portfolio

1.33%

Previous 1.55%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	BUY	$713.71 - $898.95 $234,096 - $294,855	328 Added 0.52%	63,791 $49.7 Million
Q1 2025 Apr 28, 2025	BUY	$725.72 - $929.72 $13,788 - $17,664	19 Added 0.03%	63,463 $52.4 Million
Q4 2024 Jan 17, 2025	BUY	$727.2 - $932.06 $1.37 Million - $1.75 Million	1,881 Added 3.06%	63,444 $49 Million
Q3 2024 Oct 25, 2024	BUY	$772.14 - $960.02 $40,923 - $50,881	53 Added 0.09%	61,563 $54.5 Million
Q2 2024 Jul 30, 2024	SELL	$724.87 - $909.04 $788,658 - $989,035	-1,088 Reduced 1.74%	61,510 $55.7 Million
Q1 2024 May 02, 2024	BUY	$592.2 - $792.28 $29.7 Million - $39.8 Million	50,197 Added 404.78%	62,598 $48.7 Million
Q4 2023 Jan 12, 2024	BUY	$525.19 - $619.13 $1.1 Million - $1.3 Million	2,098 Added 20.36%	12,401 $7.23 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.05 Million - $1.45 Million	-2,418 Reduced 19.01%	10,303 $5.53 Million
Q2 2023 Jul 31, 2023	BUY	$350.74 - $468.98 $631,682 - $844,632	1,801 Added 16.49%	12,721 $5.97 Million
Q1 2023 Apr 11, 2023	BUY	$310.63 - $364.82 $335,791 - $394,370	1,081 Added 10.99%	10,920 $3.75 Million
Q4 2022 Jan 12, 2023	BUY	$321.55 - $374.67 $118,330 - $137,878	368 Added 3.89%	9,839 $0
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $93,391 - $106,429	-315 Reduced 3.22%	9,471 $3.06 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $146,054 - $171,489	-524 Reduced 5.08%	9,786 $3.17 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $4,928 - $6,124	21 Added 0.2%	10,310 $2.95 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $113,549 - $140,915	-505 Reduced 4.68%	10,289 $2.84 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $188,581 - $232,076	851 Added 8.56%	10,794 $2.49 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $9,930 - $12,844	55 Added 0.56%	9,943 $2.28 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $145,094 - $187,831	883 Added 9.81%	9,888 $1.85 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $150,681 - $199,387	-1,155 Reduced 11.37%	9,005 $1.52 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $29,682 - $34,333	-203 Reduced 1.96%	10,160 $1.5 Million
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $81,442 - $98,015	597 Added 6.11%	10,363 $1.7 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $47,739 - $59,087	401 Added 4.28%	9,766 $1.36 Million
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $29,830 - $36,947	279 Added 3.07%	9,365 $1.23 Million
Q3 2019 Nov 01, 2019	BUY	$106.79 - $116.16 $17,940 - $19,514	168 Added 1.88%	9,086 $1.02 Million
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $2,769 - $3,233	-25 Reduced 0.28%	8,918 $988,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $16,919 - $19,915	-152 Reduced 1.67%	8,943 $1.16 Million
Q4 2018 Feb 15, 2019	BUY	$105.9 - $118.64 $6,036 - $6,762	57 Added 0.63%	9,095 $1.05 Million
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $209,326 - $261,621	2,438 Added 36.94%	9,038 $970,000
Q2 2018 Aug 15, 2018	BUY	$75.7 - $86.88 $38,758 - $44,482	512 Added 8.41%	6,600 $563,000
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $46,010 - $54,312	620 Added 11.34%	6,088 $471,000
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $448,047 - $480,582	5,468	5,468 $462,000

Others Institutions Holding LLY

# of Institutions

4,445

Shares Held

781M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Advisors, LLC with notifications on news.

Account

Mutual Advisors, LLC Eli Lilly & CO Transaction History